Abstract
Recurrent and chronic infections in children are one of the most common reasons for physician visits and present a diagnostic challenge to pediatricians. The majority of referred children with recurrent infections are normal. However, other underlying causes of recurrent infection such as atopy, anatomical and functional defects, and primary and secondary immunodeficiencies must be considered in evaluation of children with this complaint.
Keywords
- Chronic Lymphocytic Leukemia
- Correct Answer
- Total Parenteral Nutrition
- Recurrent Infection
- Primary Immunodeficiency Disease
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Campbell H (1995) Acute respiratory infection: a global challenge. Arch Dis Child 73(4):281–283
Gruber C, Keil T, Kulig M, Roll S, Wahn U, Wahn V (2008) History of respiratory infections in the first 12 yr among children from a birth cohort. Pediatr Allergy Immunol 19(6):505–512
Monto AS (1995) Viral respiratory infections in the community: epidemiology, agents, and interventions. Am J Med 99(6B):24S–27S
American Academy of Pediatrics Committee on Environmental Health (1997) Environmental tobacco smoke: a hazard to children. Pediatrics 99(4):639–642
Geha RS, Notarangelo LD, Casanova JL, Chapel H, Conley ME, Fischer A, Hammarstrom L, Nonoyama S, Ochs HD, Puck JM, Roifman C, Seger R, Wedgwood J (2007) Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. J Allergy Clin Immunol 120(4):776–794
Bruton OC (1952) Agammaglobulinemia. Pediatrics 9:722–728
Fudenberg HH, Good RA, Hitzig W, Kunkel HG, Roitt IM, Rosen FS, Rowe DS, Seligmann M, Soothill JR (1970) Classification of the primary immune deficiencies: WHO recommendation. N Engl J Med 283(12):656–657
Al-Herz W, Bousfiha A, Casanova JL, Chapel H, Conley ME, Cunningham-Rundles C, Etzioni A, Fischer A, Franco JL, Geha RS, Hammarstrom L, Nonoyama S, Notarangelo LD, Ochs H, Puck JM, Roifman C, Seger R, Tang ML (2011) Primary immunodeficiency diseases: an update on the classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency.. Front Immunol 2(54):1–26
Skoda-Smith S, Barrett DJ (2000) When earaches and sore throats become more than a pain in the neck. Contemp Pediatr 17:156
Bush A (2009) Recurrent respiratory infections. Pediatr Clin North Am 56(1):67–100, x
Bonilla FA, Bernstein IL, Khan DA, Ballas ZK, Chinen J, Frank MM, Kobrynski LJ, Levinson AI, Mazer B, Nelson RP Jr, Orange JS, Routes JM, Shearer WT, Sorensen RU (2005) Practice parameter for the diagnosis and management of primary immunodeficiency. Ann Allergy Asthma Immunol 94(5 Suppl 1):S1–S63
Stiehm ER, Ochs HD, Winkelstein JA (2004) Immunodeficiency disorders: general considerations. In: Stiehm ER, Ochs HD, Winkelstein JA (eds) Immunologic disorders in infants and children, 5th edn. Elsevier/Saunders, Philadelphia, pp 289–355
Ballow M (2008) Approach to the patient with recurrent infections. Clin Rev Allergy Immunol 34(2):129–140
Slatter MA, Gennery AR (2008) Clinical immunology review series: an approach to the patient with recurrent infections in childhood. Clin Exp Immunol 152(3):389–396
McKinney RE Jr, Katz SL, Wilfert CM (1987) Chronic enteroviral meningoencephalitis in agammaglobulinemic patients. Rev Infect Dis 9(2):334–356
Wilfert CM, Buckley RH, Mohanakumar T, Griffith JF, Katz SL, Whisnant JK, Eggleston PA, Moore M, Treadwell E, Oxman MN, Rosen FS (1977) Persistent and fatal central-nervous-system ECHOvirus infections in patients with agammaglobulinemia. N Engl J Med 296(26):1485–1489
Winkelstein JA, Marino MC, Johnston RB Jr, Boyle J, Curnutte J, Gallin JI, Malech HL, Holland SM, Ochs H, Quie P, Buckley RH, Foster CB, Chanock SJ, Dickler H (2000) Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) 79(3):155–169
Fischer A (2001) Primary T-lymphocyte immunodeficiencies. Clin Rev Allergy Immunol 20(1):3–26
Fischer A (2000) Severe combined immunodeficiencies (SCID). Clin Exp Immunol 122(2):143–149
Ellison RT 3rd, Kohler PF, Curd JG, Judson FN, Reller LB (1983) Prevalence of congenital or acquired complement deficiency in patients with sporadic meningocococcal disease. N Engl J Med 308(16):913–916
Lim D, Gewurz A, Lint TF, Ghaze M, Sepheri B, Gewurz H (1976) Absence of the sixth component of complement in a patient with repeated episodes of meningococcal meningitis. J Pediatr 89(1):42–47
Zoppi M, Weiss M, Nydegger UE, Hess T, Spath PJ (1990) Recurrent meningitis in a patient with congenital deficiency of the C9 component of complement. First case of C9 deficiency in Europe. Arch Intern Med 150(11):2395–2399
Potter PC, Frasch CE, van der Sande WJ, Cooper RC, Patel Y, Orren A (1990) Prophylaxis against Neisseria meningitidis infections and antibody responses in patients with deficiency of the sixth component of complement. J Infect Dis 161(5):932–937
de Vries E (2006) Patient-centred screening for primary immunodeficiency: a multi-stage diagnostic protocol designed for non-immunologists. Clin Exp Immunol 145(2):204–214
Puck JM (2007) Neonatal screening for severe combined immune deficiency. Curr Opin Allergy Clin Immunol 7(6):522–527
Schwartzwald H (2011) Fever in human immunodeficiency virus-infected infants and children. In: Basow DS (ed) UpToDate. UpToDate, Waltham
Kaplan JE, Benson C, Holmes KH, Brooks JT, Pau A, Masur H (2009) Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep 58(RR-4):1–207, quiz CE201-204
Mueller BU (1999) Cancers in children infected with the human immunodeficiency virus. Oncologist 4(4):309–317
Antinori A, Ammassari A, Torti C, Marconi P, Andreoni M, Angarano G, Bonora S, Castagna A, Cauda R, Clerici M, Monforte A, De Luca A, Di Perri G, Galli M, Girardi E, Gori A, Lazzarin A, Lo Caputo S, Mazzotta F, Montella F, Mussini C, Perno CF, Puoti M, Rizzardini G, Rusconi S, Vullo V, Carosi G (2009) Italian consensus statement on management of HIV-infected individuals with advanced disease naive to antiretroviral therapy. Infection 37(3):270–282
Working Group on Antiretroviral Therapy and Medical Management of HIV-Infected Children (2009). Guidelines for the use of antiretroviral agents in pediatric HIV infection. HIV Clinic Trial 33:24–29
Shelburne SA, Visnegarwala F, Darcourt J, Graviss EA, Giordano TP, White AC Jr, Hamill RJ (2005) Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy. AIDS 19(4):399–406
Robertson J, Meier M, Wall J, Ying J, Fichtenbaum CJ (2006) Immune reconstitution syndrome in HIV: validating a case definition and identifying clinical predictors in persons initiating antiretroviral therapy. Clin Infect Dis 42(11):1639–1646
Working Group on Antiretroviral Therapy and Medical Management of HIV-Infected Children (2009). Guidelines for the use of antiretroviral agents in pediatric HIV infection. HIV Clinic Trial 33:75–78, 96–97
Shelburne SA, Montes M, Hamill RJ (2006) Immune reconstitution inflammatory syndrome: more answers, more questions. J Antimicrob Chemother 57(2):167–170
Murdoch DM, Venter WD, Feldman C, Van Rie A (2008) Incidence and risk factors for the immune reconstitution inflammatory syndrome in HIV patients in South Africa: a prospective study. AIDS 22(5):601–610
Lawn SD, Myer L, Bekker LG, Wood R (2007) Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa. AIDS 21(3):335–341
Phillips P, Bonner S, Gataric N, Bai T, Wilcox P, Hogg R, O’Shaughnessy M, Montaner J (2005) Nontuberculous mycobacterial immune reconstitution syndrome in HIV-infected patients: spectrum of disease and long-term follow-up. Clin Infect Dis 41(10):1483–1497
Wormser GP, Horowitz H, Dworkin B (1994) Low-dose dexamethasone as adjunctive therapy for disseminated Mycobacterium avium complex infections in AIDS patients. Antimicrob Agents Chemother 38(9):2215–2217
de Vries E (2006) Patient-centred screening for primary immunodeficiency: a multi-stage diagnostic protocol designed for non-immunologists. Clinical Working Party of the European Society for Immunodeficiencies (ESID). Clin Exp Immunol. 145(2):204–14
Feugier P, Tomowiak C, Daguindau N, Perrot A (2007) Secondary deficiencies of humoral immunity in hematology: what management? Rev Med Interne. 28(2):1.
Vignes S, Bellanger J (2008) Primary intestinal lymphangiectasia (Waldmann’s disease). Orphanet J Rare Dis 3:5
Hauser B, Moreels T, Urbain D, Van Marck V, Pletincx M, Devreker T, Vandenplas Y (2009) Intestinal lymphangiectasia. J Pediatr Gastroenterol Nutr 48(2):125
Camarero C, Tamariz R, Garcia Trujillo JA, Villagra F, Escobar H, Suarez L, Cazzaniga M, Leon F (2001) Protein-losing enteropathy after Fontan’s operation. An Pediatr (Barc) 54(Suppl 3):39–42
Yang DM, Jung DH (2003) Localized intestinal lymphangiectasia: CT findings. AJR Am J Roentgenol 180(1):213–214
Strober W, Wochner RD, Carbone PP, Waldmann TA (1967) Intestinal lymphangiectasia: a protein-losing enteropathy with hypogammaglobulinemia, lymphocytopenia and impaired homograft rejection. J Clin Invest 46(10):1643–1656
Weiden PL, Blaese RM, Strober W, Block JB, Waldmann TA (1972) Impaired lymphocyte transformation in intestinal lymphangiectasia: evidence for at least two functionally distinct lymphocyte populations in man. J Clin Invest 51(6):1319–1325
Heresbach D, Raoul JL, Genetet N, Noret P, Siproudhis L, Ramee MP, Bretagne JF, Gosselin M (1994) Immunological study in primary intestinal lymphangiectasia. Digestion 55(1):59–64
Fuss IJ, Strober W, Cuccherini BA, Pearlstein GR, Bossuyt X, Brown M, Fleisher TA, Horgan K (1998) Intestinal lymphangiectasia, a disease characterized by selective loss of naive CD45RA + lymphocytes into the gastrointestinal tract. Eur J Immunol 28(12):4275–4285
Alfano V, Tritto G, Alfonsi L, Cella A, Pasanisi F, Contaldo F (2000) Stable reversal of pathologic signs of primitive intestinal lymphangiectasia with a hypolipidic, MCT-enriched diet. Nutrition 16(4):303–304
Chen CP, Chao Y, Li CP, Lo WC, Wu CW, Tsay SH, Lee RC, Chang FY (2003) Surgical resection of duodenal lymphangiectasia: a case report. World J Gastroenterol 9(12):2880–2882
Brown RE, Katz M (1966) Failure of antibody production to yellow fever vaccine in children with kwashiorkor. Trop Geogr Med 18(2):125–128
Dionigi R, Zonta A, Dominioni L, Gnes F, Ballabio A (1977) The effects of total parenteral nutrition on immunodepression due to malnutrition. Ann Surg 185(4):467–474
Alper CA, Johnson AM, Birtch AG, Moore FD (1969) Human C’3: evidence for the liver as the primary site of synthesis. Science 163(864):286–288
Lord GM, Matarese G, Howard JK, Baker RJ, Bloom SR, Lechler RI (1998) Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 394(6696):897–901
Altay C, Dogramaci N, Bingol A, Say B (1972) Nitroblue tetrazolium test in children with malnutrition. J Pediatr 81(2):392–393
Baker SS, Lerman RH, Krey SH, Crocker KS, Hirsh EF, Cohen H (1983) Selenium deficiency with total parenteral nutrition: reversal of biochemical and functional abnormalities by selenium supplementation: a case report. Am J Clin Nutr 38(5):769–774
Carton JA, Maradona JA, Nuno FJ, Fernandez-Alvarez R, Perez-Gonzalez F, Asensi V (1992) Diabetes mellitus and bacteraemia: a comparative study between diabetic and non-diabetic patients. Eur J Med 1(5):281–287
Bessman AN, Sapico FL (1992) Infections in the diabetic patient: the role of immune dysfunction and pathogen virulence factors. J Diabetes Complications 6(4):258–262
Li Volti S, Caruso-Nicoletti M, Biazzo F, Sciacca A, Mandara G, Mancuso M, Mollica F (1998) Hyporesponsiveness to intradermal administration of hepatitis B vaccine in insulin dependent diabetes mellitus. Arch Dis Child 78(1):54–57
Alleyne CH Jr, Vishteh AG, Spetzler RF, Detwiler PW (1999) Long-term survival of a patient with invasive cranial base rhinocerebral mucormycosis treated with combined endovascular, surgical, and medical therapies: case report. Neurosurgery 45(6):1461–1463; discussion 1463–1464
Moutschen MP, Scheen AJ, Lefebvre PJ (1992) Impaired immune responses in diabetes mellitus: analysis of the factors and mechanisms involved. Relevance to the increased susceptibility of diabetic patients to specific infections. Diabete Metab 18(3):187–201
Geerlings SE, Hoepelman AI (1999) Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol 26(3–4):259–265
Scavella A, Leiva L, Monjure H, Zea AH, Gardner RV (2010) Effect of L-arginine supplementation on immune responsiveness in patients with sickle cell disease. Pediatr Blood Cancer 55(2):318–323
Holdsworth RJ, Irving AD, Cuschieri A (1991) Postsplenectomy sepsis and its mortality rate: actual versus perceived risks. Br J Surg 78(9):1031–1038
Carsetti R, Pantosti A, Quinti I (2006) Impairment of the antipolysaccharide response in splenectomized patients is due to the lack of immunoglobulin M memory B cells. J Infect Dis 193(8):1189–1190
Musher DM, Ceasar H, Kojic EM, Musher BL, Gathe JC Jr, Romero-Steiner S, White AC Jr (2005) Administration of protein-conjugate pneumococcal vaccine to patients who have invasive disease after splenectomy despite their having received 23-valent pneumococcal polysaccharide vaccine. J Infect Dis 191(7):1063–1067
Shatz DV (2002) Vaccination practices among North American trauma surgeons in splenectomy for trauma. J Trauma 53(5):950–956
de Marie S (1993) Diseases and drug-related interventions affecting host defence. Eur J Clin Microbiol Infect Dis 12(Suppl 1):S36–S41
Donati D, Degiannis D, Homer L, Gastaldi L, Raskova J, Raska K Jr (1991) Immune deficiency in uremia: interleukin-2 production and responsiveness and interleukin-2 receptor expression and release. Nephron 58(3):268–275
Harris RC, Ismail N (1994) Extrarenal complications of the nephrotic syndrome. Am J Kidney Dis 23(4):477–497
Krensky AM, Ingelfinger JR, Grupe WE (1982) Peritonitis in childhood nephrotic syndrome: 1970–1980. Am J Dis Child 136(8):732–736
Sakuma Y, Katoh T, Owada K, Suzuki H, Sakurai K, Eiro M, Asahi K, Watanabe T (2005) Initial functional status predicts infections during steroid therapy for renal diseases. Clin Nephrol 63(2):68–73
Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M (1995) Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 270(5234):286–290
Andersson J, Nagy S, Groth CG, Andersson U (1992) Effects of FK506 and cyclosporin A on cytokine production studied in vitro at a single-cell level. Immunology 75(1):136–142
Russell RG, Graveley R, Coxon F, Skjodt H, Del Pozo E, Elford P, Mackenzie A (1992) Cyclosporin A. Mode of action and effects on bone and joint tissues. Scand J Rheumatol Suppl 95:9–18
Rao VK, Dugan F, Dale JK, Davis J, Tretler J, Hurley JK, Fleisher T, Puck J, Straus SE (2005) Use of mycophenolate mofetil for chronic, refractory immune cytopenias in children with autoimmune lymphoproliferative syndrome. Br J Haematol 129(4):534–538
Mele TS, Halloran PF (2000) The use of mycophenolate mofetil in transplant recipients. Immunopharmacology 47(2–3):215–245
Segal BH, Sneller MC (1997) Infectious complications of immunosuppressive therapy in patients with rheumatic diseases. Rheum Dis Clin North Am 23(2):219–237
Ehrke MJ, Mihich E, Berd D, Mastrangelo MJ (1989) Effects of anticancer drugs on the immune system in humans. Semin Oncol 16(3):230–253
Lee AH, Levinson AI, Schumacher HR Jr (1993) Hypogammaglobulinemia and rheumatic disease. Semin Arthritis Rheum 22(4):252–264
Sinisalo M, Aittoniemi J, Koski T, Tobin G, Thunberg U, Sundstrom C, Rosenquist R, Kayhty H, Vilpo J (2004) Similar humoral immunity parameters in chronic lymphocytic leukemia patients independent of VH gene mutation status. Leuk Lymphoma 45(12):2451–2454
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Aghamohammadi, A., Abolhassani, H., Caracseghi, F., Soler-Palacin, P. (2012). Recurrent Infections. In: Aghamohammadi, A., Rezaei, N. (eds) Clinical Cases in Primary Immunodeficiency Diseases. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-31785-9_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-31785-9_1
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-31784-2
Online ISBN: 978-3-642-31785-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)